Cargando…
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis
Cancer clinical trial eligibility criteria may create patient populations studied in trials that do not reflect the patient populations treated in the real-world setting. Follicular lymphoma (FL) is an indolent lymphoma with heterogeneous presentations across a broad range of individuals, resulting...
Autores principales: | Luan, Danny, Fatola, Tolulope, Toure, Ahmed, Flowers, Christopher R., Link, Brian, Friedberg, Jonathan W., Cohen, Jonathon B., Kahl, Brad, Lossos, Izidore S., Nastoupil, Loretta, Maurer, Matthew J., Cerhan, James R., Martin, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636310/ https://www.ncbi.nlm.nih.gov/pubmed/35793440 http://dx.doi.org/10.1182/bloodadvances.2022007687 |
Ejemplares similares
-
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States
por: Nastoupil, Loretta J, et al.
Publicado: (2014) -
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
por: Harkins, R. Andrew, et al.
Publicado: (2022) -
Exploring Risk Factors for Follicular Lymphoma
por: Ambinder, Alexander J., et al.
Publicado: (2012) -
Atypical follicular hyperplasia with light chain–restricted germinal centers after COVID-19 booster: a diagnostic pitfall
por: Patil, Ashish, et al.
Publicado: (2022) -
Léo Ferré
por: Ferré, Léo
Publicado: (1999)